Why Farbe Firma is the Top Manufacturer of Ondansetron Injection
- Maulik Sudani
- 7 hours ago
- 3 min read
Last Updated: May 18, 2026
TL;DR: Farbe Firma Pvt Ltd, a WHO-GMP certified pharmaceutical manufacturer in Ankleshwar, Gujarat, India, is one of the most trusted producers and CMO partners for Ondansetron Injection, supplying sterile ampoule and vial product to hospitals, oncology centres, distributors, and government tenders across 30+ countries.
Key Takeaways
Ondansetron Injection is a 5-HT3 antagonist antiemetic used to prevent chemotherapy-, radiotherapy- and surgery-induced nausea and vomiting.
Farbe Firma is a WHO-GMP certified, ISO 9001:2015 compliant manufacturer with ISO Class 5 (Grade A) sterile core and 100+ injectable SKUs.
CTD/ACTD-dossier-supported ondansetron ampoules and vials are exported to 30+ countries across Latin America, CIS, Africa, Middle East and South-East Asia.
Full CMO/CDMO services: formulation R&D, scale-up, ICH stability, primary/secondary packaging and regulatory support under one roof in Gujarat, India.
Introduction: Why Ondansetron Injection Demands a Premium Manufacturer
Ondansetron Injection is a selective 5-HT3 receptor antagonist used worldwide to prevent and treat chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea, and post-operative nausea and vomiting (PONV). It is a high-volume hospital injectable that appears on virtually every Ministry of Health essential medicines list. Every ampoule and vial must satisfy USP / BP / IP monograph requirements for assay, related substances, particulate matter, bacterial endotoxin (LAL) and sterility.
That is exactly the operating bar Farbe Firma Pvt Ltd has set since establishing its WHO-GMP certified sterile injectable facility in Ankleshwar, Gujarat, India. With ISO Class 5 (Grade A) laminar airflow filling, validated terminal sterilization, and end-to-end batch traceability, Farbe Firma has become a preferred Ondansetron Injection manufacturer for hospital procurement chains, oncology pharmacies, importers and government tender buyers worldwide.
What Sets a World-Class Ondansetron Manufacturer Apart
Manufacturing parenteral ondansetron is technically demanding. The product must pass clarity, sub-visible particulate (USP <788>), bacterial endotoxin (LAL), sterility and assay tests at every batch. Farbe Firma's ondansetron line uses Type I borosilicate glass ampoules and vials, validated terminal sterilization, and 100% visual plus automated particulate inspection.
Equally important is regulatory readiness. Ondansetron is registered as a prescription parenteral in essentially every market. Farbe Firma's regulatory affairs team has supported dossier submissions and product registrations across Latin America, Africa, the GCC, CIS and ASEAN - making us a CDMO partner rather than just a vendor.
Quality Systems Behind Every Ondansetron Ampoule
Each batch of Ondansetron Injection at Farbe Firma passes through tightly controlled in-process checks: pre-sterilization bioburden, fill-volume verification, post-fill leak testing, terminal sterilization cycle validation, and finished-product assay against the relevant pharmacopoeia. Stability programs run at 25C/60% RH and 40C/75% RH per ICH Q1A(R2) guidelines, supporting 24-36 month shelf life claims.
Documentation includes batch manufacturing records (BMR), batch packaging records (BPR), validated cleaning records, environmental monitoring data and qualified-person review - all retained and reproducible for any future audit.
Why Farbe Firma is the Trusted Ondansetron Injection Manufacturer for Global Buyers
Farbe Firma Pvt Ltd is a WHO-GMP certified, ISO 9001:2015 compliant pharmaceutical manufacturer headquartered in Gujarat, India. The facility is designed around dedicated injectable suites with ISO Class 5 sterile core. The plant supplies 100+ injectable SKUs and exports to 30+ countries.
Beyond manufacturing, Farbe Firma operates as a true CDMO. We support contract development from formulation through validation, scale-up, dossier preparation, product registration assistance and life-cycle management.
Pricing, lead-time and MOQ flexibility are why distributors, hospital groups and government tender buyers choose Farbe Firma year after year. WHO-GMP quality, on-time delivery, complete documentation.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma's Ondansetron Injection WHO-GMP certified?
Yes. The entire injectable facility operates under valid WHO-GMP certification, ISO 9001:2015 quality management, and ISO Class 5 sterile core conditions.
What ampoule and vial sizes and strengths are available?
Standard configurations include 4 mg/2 mL and 8 mg/4 mL clear Type I glass ampoules, plus 8 mg/4 mL vial packs for multi-dose hospital use.
Is the product suitable for oncology hospital tenders?
Yes. Farbe Firma's Ondansetron Injection is routinely supplied into Ministry of Health and large oncology hospital tenders across Latin America, CIS, Africa and South-East Asia.
Do you provide CTD/ACTD dossiers for Ondansetron Injection?
Yes. Our regulatory affairs team prepares complete CTD or ACTD dossiers.
What is the minimum order quantity and lead time for Ondansetron Injection?
Typical MOQ starts from 25,000 ampoules per SKU; lead time ranges 6-10 weeks from purchase order.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | director@farbefirma.org | Gujarat, INDIA
Comments